Christopher Haley is a Dermatology physician affiliated with Baylor Scott & White Health. OpenAlex indexes 23 publications with 486 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765080001
Telephone
254-724-2111Provider last certified this registry record 13 Jul 2022.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20241 payment
- Janssen Scientific Affairs, LLCProgram year20221 payment
- E.R. Squibb & Sons, L.L.C.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
40.3%Azole Antifungal16.8%Ketoconazole90%Fluconazole10%Part D≥90 patientsFirst-generation cephalosporins9.2%Cephalexin100%Part D≥86 patients+ 4 more classes in this area
Sensory organs
18.2%Corticosteroid18.2%Clobetasol Propionate52%Hydrocortisone48%Part D≥57 patientsDermatology
17%Corticosteroid8.9%Triamcinolone Acetonide89%Fluocinolone Acetonide11%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist3.4%Dupixent Pen100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Severity of Initial Unilateral Cleft Lip and Nasal Deformity Predicts Long-Term Postoperative Esthetic Outcome
Journal of Craniofacial Surgery
2024 - 33613 Rare infectious diseases encountered in a dermatologic setting
Journal of the American Academy of Dermatology
2022 - 27736 Painful retiform purpura with cutaneous necrosis
Journal of the American Academy of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Karen Fink, PhD, MD
Baylor Scott & White Health
Garry Schwartz, MD
Baylor Scott & White Health
Robert Hebeler, MD
Baylor Scott & White Health
Harry Papaconstantinou, MD
Baylor Scott & White Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”